Delivery Order SPE2DB20D2014-SPE2DB24FB31J
Award Date 3/12/24
Potential Completion Date 3/13/24
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product, with a ceiling value of $5,872.24 and a performance period ending on July 14, 2025. The contract is a Firm Fixed Price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,232.46, is for the delivery of DALIRESP 250 MCG TABLET UU 28S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $1,046.95 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DALIRESP 500 MCG TABLET 30S and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALIRESP 250 MCG TABLET UD 20S, with a total ceiling value of $3,443.05 and a period of performance through March 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,903.97 Firm Fixed Price delivery order is for the supply of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DALIRESP 500 MCG TABLET 90S. The contract has a firm-fixed price of $25,523.62 and a period of performance through July 9, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical,...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,890.98, is for the delivery of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 9, 2025 and is a Firm Fixed Price contract. No set-aside designation is mentioned. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB23FS49C, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 6, 2023. The $3,667.14 firm-fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The contract has a completion date of March 7, 2023 and is not designated under any set-aside category. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite...
- This is a $2,844.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product, with a period of performance through February 4, 2025. The contract is not designated as a set-aside. It appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DALIRESP 500 MCG TABLET 30S. The contract has a ceiling value of $33,557.38 and runs through February 4, 2025. The contract is a Firm Fixed Price type and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...